A recent study provides a longitudinal overview of symptomatic and immunosuppressive drugs used in Lambert-Eaton myasthenic syndrome (LEMS). This research highlights treatment patterns and outcomes, contributing to the understanding of LEMS management.
longitudinal overview of symptomatic and immunosuppressive drugs in lems
Original title: “Longitudinal overview of symptomatic and immunosuppressive drugs in LEMS.”